Behavioural and psychiatric symptoms in cognitive neurology

Neurología : publicación oficial de la Sociedad Española de Neurología
A Robles Bayón, F Gude Sampedro

Abstract

Behavioural and psychiatric symptoms (BPS) are frequent in neurological patients, contribute to disability, and decrease quality of life. We recorded BPS prevalence and type, as well as any associations with specific diagnoses, brain regions, and treatments, in consecutive outpatients examined in a cognitive neurology clinic. A retrospective analysis of 843 consecutive patients was performed, including a review of BPS, diagnosis, sensory impairment, lesion topography (neuroimaging), and treatment. The total sample was considered, and the cognitive impairment (CI) group (n=607) was compared to the non-CI group. BPS was present in 59.9% of the patients (61.3% in the CI group, 56.4% in the non-CI group). One BPS was present in 31.1%, two in 17.4%, and three or more in 11.4%. BPS, especially depression and anxiety, are more frequent in women than in men. Psychotic and behavioural symptoms predominate in subjects aged 65 and older, and anxiety in those younger than 65. Psychotic symptoms appear more often in patients with sensory impairment. Psychotic and behavioural symptoms are more prevalent in patients with degenerative dementia; depression and anxiety in those who suffer a psychiatric disease or adverse effects of substances; e...Continue Reading

References

Feb 1, 1983·The American Journal of Psychiatry·R B Schiffer
Jan 1, 1994·The Journal of Neuropsychiatry and Clinical Neurosciences·D AmesM Mahler
Jul 1, 1993·Journal of the American Geriatrics Society·J PitnerJ Mintzer
Aug 1, 1993·Neurology·G J Gilbert
Oct 1, 1995·The British Journal of Psychiatry : the Journal of Mental Science·C BallardG Wilcock
Feb 1, 1997·The Journal of Nervous and Mental Disease·S E Starkstein, R G Robinson
Jun 6, 2000·Journal of Affective Disorders·C BallardR Perry
Oct 14, 2000·Journal of Neurology, Neurosurgery, and Psychiatry·A J Hudson, G M Grace
May 13, 2003·Molecular Psychiatry·R A SweetD V Jeste
Jul 29, 2003·Journal of Neurology·Marie SarazinPanteleimon Giannakopoulos
Dec 23, 2003·Journal of the American Geriatrics Society·Anne-Mette HejlGunhild Waldemar
Jul 29, 2004·Proceedings of the National Academy of Sciences of the United States of America·Qiang WeiHuda Akil
May 18, 2005·Journal of Neurology, Neurosurgery, and Psychiatry·R Uher, J Treasure
Sep 30, 2005·International Psychogeriatrics·John O'Brien
Nov 25, 2005·The American Journal of Geriatric Pharmacotherapy·Ralph W Richter
Nov 26, 2005·Primary Care Companion to the Journal of Clinical Psychiatry·Rebecca W Brendel, Theodore A Stern
Jan 24, 2007·NeuroImage·Jennifer L WhitwellJason D Warren
May 26, 2007·Clinical Drug Investigation·Galina PassareJohan Fastbom
Sep 12, 2007·Social Psychiatry and Psychiatric Epidemiology·Satu ViertiöJaana Suvisaari
May 5, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·Farrah J Mateen, Keith A Josephs
Jul 6, 2010·Journal of Geriatric Psychiatry and Neurology·Svante OstlingMargda Waern
Aug 6, 2010·Neurobiology of Aging·Petroula ProitsiJohn F Powell
Mar 4, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Jesus D MenaBrian A Baldo
May 20, 2011·CNS Neuroscience & Therapeutics·Lothar BurghausNico J Diederich
Jan 10, 2012·Journal of Neurology, Neurosurgery, and Psychiatry·Kelly Bertram, David R Williams
Jan 31, 2012·Journal of Intellectual Disability Research : JIDR·A M Muehlmann, M H Lewis
Dec 12, 2012·Trends in Neurosciences·Pierre-Eric Lutz, Brigitte L Kieffer
Apr 17, 2013·Pflügers Archiv : European journal of physiology·Nina C Donner, Christopher A Lowry
Jun 19, 2013·Expert Opinion on Pharmacotherapy·Hong YouJinnan Zhang
Sep 21, 2013·Expert Opinion on Pharmacotherapy·Chi-Un Pae
Dec 29, 2013·Journal of Affective Disorders·Ajay K ParsaikTeresa A Rummans
Mar 7, 2014·Neuropsychiatric Disease and Treatment·Koichi BannoTatsuo Akechi
Jun 3, 2014·Frontiers in Neuroendocrinology·Margaret AltemusC Neill Epperson
Sep 16, 2014·Annals of Indian Academy of Neurology·Tushar Kanti BandyopadhyayAsit Kumar Senapati
Nov 19, 2014·Journal of the American Medical Directors Association·Christophe HeinFati Nourhashémi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

Acta Neurologica Scandinavica. Supplementum
I Karlsson
Journal of Neurology, Neurosurgery, and Psychiatry
L S WilliamsK Kroenke
Psychiatric Services : a Journal of the American Psychiatric Association
S S Levitte, W F Hoffman
Nederlands tijdschrift voor geneeskunde
C de Rijk, R V Bijl
© 2022 Meta ULC. All rights reserved